Cargando…
Urinary Metabolomic Profiling in Streptozotocin-Induced Diabetic Mice after Treatment with Losartan
Diabetic kidney disease (DKD) is the leading cause of chronic kidney disease and end-stage kidney disease. Renin–angiotensin system inhibitors such as losartan are the predominant therapeutic options in clinical practice to treat DKD. Therefore, it is necessary to identify DKD-related metabolic prof...
Autores principales: | Hyeon, Jin Seong, Jung, Youngae, Lee, Gayoung, Ha, Hunjoo, Hwang, Geum-Sook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730544/ https://www.ncbi.nlm.nih.gov/pubmed/33255934 http://dx.doi.org/10.3390/ijms21238969 |
Ejemplares similares
-
Urinary Metabolomic Profiling Analysis and Evaluation of the Effect of Ecklonia cava Extract Intake
por: Kim, Juyeon, et al.
Publicado: (2020) -
Urinary myo-inositol is associated with the clinical outcome in focal segmental glomerulosclerosis
por: An, Jung Nam, et al.
Publicado: (2019) -
A novel pan-Nox inhibitor, APX-115, protects kidney injury in streptozotocin-induced diabetic mice: possible role of peroxisomal and mitochondrial biogenesis
por: Kwon, Guideock, et al.
Publicado: (2017) -
Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance
por: Kwon, Soie, et al.
Publicado: (2023) -
Gender-Specific Metabolomic Profiling of Obesity in Leptin-Deficient ob/ob Mice by (1)H NMR Spectroscopy
por: Won, Eun-Young, et al.
Publicado: (2013)